The mother's eyes turned yellow among other side effects while on Mounjaro, which had a devastating effect on her gallbladder ...

Eli Lilly and Company (NYSE:LLY) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Eli Lilly and Company ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

Topline results from the SURPASS-CVOT trial show that once-weekly tirzepatide has a cardiovascular risk profile similar to ...

The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...

Diabetes drug Mounjaro helped people lose 16% of weight, study finds Two trials have now found tirzepatide, sold under the brand name Mounjaro as a diabetes treatment, to be effective for weight loss.

Tirzepatide, sold under the brand names Zepbound and Mounjaro, is a prescription medication that works for weight loss by reducing appetite and increasing satiety. Administered as a once-weekly ...

Both Ozempic, or semaglutide, and Mounjaro, or tirzepatide, mimic the effects of the gut hormone GLP-1, which stimulates the body's production of insulin and slows the passage of food through the ...

Mounjaro patients were also 2.6 times more likely to achieve 10% weight loss and 1.8 times more likely to lose 5% of their weight, according to Truveta, which was earlier reported on by CNBC.